Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1988 Oxford University Press

research-article

Endometrial Cancer and Combined Oral Contraceptives

THE WHO COLLABORATIVE STUDY OF NEOPLASIA AND STEROID CONTRACEPTIVES

This is a report on the relationship of combined oral contraceptives to risk of endometrial cancer from a multinational hospital-based case-control study of various steroid contraceptives and five different cancers. Based on data on 130 cases and 835 matched controls from nine participating centres in seven developing countries and two participating centres in two developed countries, the relative risk of endometrial carcinoma in women who ever took combined oral contraceptives was estimated to be 0.55. This value is similar to estimates from prior investigations in the US and Italy, and the protective effect observed in this study was at least as great in the developing countries with low incidence rates as in the developed countries with higher rates. The reduction in risk was observed for adenocarcinomas with and without squamous elements.

Revised 1 July 1987


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. C. Rodriguez, B.J. Rimel, W. Watkin, J. M. Turbov, C. Barry, H. Du, G. L. Maxwell, and J.M. Cline
Progestin Treatment Induces Apoptosis and Modulates Transforming Growth Factor-{beta} in the Uterine Endometrium
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 578 - 584.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
J. Vrbikova and D. Cibula
Combined oral contraceptives in the treatment of polycystic ovary syndrome
Hum. Reprod. Update, May 1, 2005; 11(3): 277 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
ESHRE Capri Workshop Group
Hormones and breast cancer
Hum. Reprod. Update, July 1, 2004; 10(4): 281 - 293.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
E. DELIGEOROGLOU, E. MICHAILIDIS, and G. CREATSAS
Oral Contraceptives and Reproductive System Cancer
Ann. N.Y. Acad. Sci., November 1, 2003; 997(1): 199 - 208.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.